February 26, 2018
CBC is inviting new applications for the Accelerator Award program
Accelerator Award is a milestone-driven award program ($100,000 for 1st year) focused on translational research toward therapeutics or associated biomarkers and diagnostics.
Fall 2018 round Letter of Intent (LOI) submissions open at 8:00 AM on June 4, 2018 and close at 5:00 PM on June 8, 2018.
If you plan to apply, please make sure that you are conforming to the MOST RECENT RFA. Applications not conforming to the specified guidelines will NOT be accepted. In addition, applicants, if selected, MUST be available to present their projects at a CBCAN meeting on August 2 and/or August 16, 2018. Both meetings will be held on a Thursday, from 4:00-7:00 PM, at Prentice Women Hospital Conference Center downtown Chicago. MARK YOUR CALENDARS!
CBC Executive Director Jim Audia was an invited guest of iBIO President and CEO, John Conrad at Thursday’s (April 12, 2018) iBIO Board meeting, hosted by Takeda Pharmaceuticals. While there, Jim shared with the group his evolving vision for CBC as the Phase 2 programming is becoming a reality, and highlighted several of the current programs, including the CBC Accelerator Network (CBCAN) and the three CBC award programs: Accelerator, Catalyst and Entrepreneurial Fellows.
The Spring 2018 Illinois Innovation Index, recently published by the Illinois Science & Technology Coalition (ISTC) and titled: “University Entrepreneurship Index: Startup Activity Reaches New Heights,” highlights a variety of university-driven entrepreneurial efforts in Illinois. All three CBC universities are recognized as important components of the economic development and innovation in Illinois. CBC is proud to share that one of the initiatives developed in the CBC Phase 2 — the CBC Accelerator Network (CBCAN) — is mentioned in the report as a member of the “Illinois’ network of organizations and initiatives dedicated to supporting and funding entrepreneurs.” Launched in early 2017, CBCAN is now an established forum regularly bringing together industry experts, university tech transfer officers, researchers and others from the local and extended biomedical ecosystem to help promising discoveries that may have commercial potential move forward in the pipeline towards commercialization.
April 13, 2018
Past CBC awardee and frequent presenter at CBC-organized events, Rick Silverman, NU, highlighted in the journal Science, for his work to develop novel anti-addiction drugs
The opioid epidemic is on the rise — in 2016 it took more than 42,000 lives in the U.S., more than in any previous year. Unfortunately, current overdose treatments are not always effective and/or available at the time of crisis. Hence, there is an urgent need for the development of quick and effective measures to curb the growing opioid addiction and its devastating, and, too frequently fatal, consequences. Richard Silverman, NU, is at the forefront of a new wave of anti-addiction drug development. A compound recently discovered by Silverman — OV329 — appears to be very promising in fighting addiction, at least in the animal studies performed so far. The below editorial by Robert Service, published today in Science, describes OV329 development and talks about other approaches in a quest for more reliable addiction antidotes. Silverman has many links to CBC: he received a CBC HTS Award (2015) and presented his research at two Annual CBC Symposia (2013 and 2017), and at the CBC Tech Day (2013). CBC congratulates Rick and celebrates this innovative and prolific scientist.
March 29, 2018
A rising tide: Chicago biomedical research institutions to receive increased NIH funding in 2018
CBC is pleased to note that its member institutions, Northwestern University, the University of Chicago and the University of Illinois at Chicago (UIC), are among the many biomedical research institutions in the greater Chicago region to benefit from increased NIH funding recently approved by Congress for 2018. Specifically targeted research areas to receive increased funding include: Alzheimer’s disease, cancer, Precision Medicine, the BRAIN initiative, and infectious diseases — key strengths of the member institutions and all areas that CBC has also supported in the past and continues to support during Phase 2. U.S. Senator Dick Durbin (D-IL) shared the news at a press conference at the Shirley Ryan AbilityLab Tuesday, March 27, 2018.
Posted by Jola Glotzer
April 20, 2018
UChicago Department of Medicine, Section of Hematology/Oncology
23rd Annual University of Chicago Developmental Therapeutics Symposium
April 25-26, 2018
UChicago Computation Institute
GlobusWorld 2018: Connecting your Research Universe
May 4, 2018
UChicago Department of Neurology
2018 Chicago Symposium on Translational Neuroscience:
The Brain-Gut Connection: Assessing the Evidence for Microbial Influence
May 10, 2018
NU Cognitive Neurology and Alzheimer’s Disease Center
24th Annual Alzheimer Day
May 16, 2018
UChicago Computation Institute
Future Compute: A Celebration of the Computation Institute
June 13-14, 2018
SBIR/STTR Grant Writing Workshop
PROPEL is hosting this 2-day Intensive Workshop, provided by BBC Entrepreneurial Training & Consulting (BBCetc), that will cover all aspects of writing SBIR/STTR grants focused on life science technologies including: eligibility, sources of funding and agency differences, understanding what reviewers look for, step-by-step instruction on how to write each section of your proposal.